WNK2 and breast carcinoma: Moreover, rottlerin was reported to enhance IL-1β (interleukin-1β)-induced COX-2 (cyclooxygenase-2) expression via activation of p38 MAPK (mitogen-activated protein kinases) in breast cancer cells [32].